Garo H Armen insider trades: Protagenic Therapeutics, Inc.\new (PTIX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Garo reports to the SEC
and 1 more company
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | PTIX | ↑ Buy | 20,000 | $0.65 | $13K | Direct | Aug 24, 2026 (3d) |
| Aug 20, 2026 | PTIX | ↑ Buy | 16,634 | $0.59 | $10K | Direct | Aug 20, 2026 (0d) |
| Aug 19, 2026 | PTIX | ↑ Buy | 2,700 | $0.35 | $945 | Direct | Aug 20, 2026 (1d) |
| Aug 11, 2026 | PTIX | ↑ Buy | 2,220 | $0.32 | $710 | Direct | Aug 12, 2026 (1d) |
| Aug 6, 2026 | PTIX | ↑ Buy | 685 | $0.22 | $151 | Direct | Aug 10, 2026 (4d) |
| Aug 5, 2026 | PTIX | ↑ Buy | 5,000 | $0.26 | $1K | Direct | Aug 6, 2026 (1d) |
| Jul 30, 2026 | PTIX | ↑ Buy | 26,291 | $0.18 | $5K | Direct | Aug 3, 2026 (4d) |
| Feb 15, 2024 | AGEN | ↑ Buy | 500,000 | $0.65 | $324K | Indirect | Feb 15, 2024 (0d) |
| May 5, 2023 | INKT | ↓ Sell | 100,000 | $0.95 | $95K | Direct | May 5, 2023 (0d) |
| May 2, 2023 | INKT | ↑ Buy | 100,000 | $0.95 | $95K | Direct | May 4, 2023 (2d) |
| Sep 13, 2021 | AGEN | ↓ Sell | 82,107 | $6.50 | $534K | Direct | Sep 14, 2021 (1d) |
| Apr 12, 2017 | AGEN | ↑ Buy | 100,000 | $3.35 | $335K | Direct | Apr 12, 2017 (0d) |
| Jun 17, 2016 | ATRND | ↑ Buy | 60,211 | $1.25 | $75K | Direct | Aug 18, 2016 (62d) |
| May 9, 2016 | AGEN | ↑ Buy | 100,000 | $3.18 | $318K | Direct | May 10, 2016 (1d) |
| Mar 7, 2016 | AGEN | ↑ Buy | 200,000 | $4.03 | $806K | Direct | Mar 8, 2016 (1d) |
| Dec 29, 2015 | AGEN | ↓ Sell | 219,576 | $4.59 | $1.0M | Direct | Dec 30, 2015 (1d) |
| Sep 25, 2015 | AGEN | ↑ Buy | 100,000 | $5.03 | $503K | Direct | Sep 29, 2015 (4d) |
| Sep 30, 2011 | AGEND | ↑ Buy | 16,666 | $2.99 | $50K | Direct | Oct 3, 2011 (3d) |
| Aug 16, 2011 | AGEN | ↑ Buy | 2,150,976 | $0.51 | $1.1M | Direct | Aug 17, 2011 (1d) |
| Mar 11, 2010 | AGEN | ↓ Sell | 87,628 | $0.79 | $69K | Direct | Mar 11, 2010 (0d) |
| Jul 16, 2009 | AGEN | ↓ Sell | 137,698 | $1.66 | $228K | Direct | Jul 17, 2009 (1d) |
| Jun 25, 2009 | AGEN | ↑ Buy | 25,000 | $1.97 | $49K | Direct | Jun 29, 2009 (4d) |
| Jan 9, 2008 | AGEN | ↑ Buy | 1,166,667 | $3.00 | $3.5M | by Armen Partners, LP | Jan 11, 2008 (2d) |
| Jan 9, 2008 | AGEN | ↑ Buy | 542,050 | $3.00 | $1.6M | Direct | Jan 11, 2008 (2d) |
| Sep 14, 2007 | AGEN | ↑ Buy | 50,000 | $2.33 | $117K | Direct | Sep 14, 2007 (0d) |
| Mar 15, 2007 | AGEN | ↑ Buy | 10,000 | $2.03 | $20K | Direct | Mar 16, 2007 (1d) |
| Mar 14, 2007 | AGEN | ↑ Buy | 25,000 | $2.00 | $50K | Direct | Mar 14, 2007 (0d) |
| Mar 12, 2007 | AGEN | ↑ Buy | 25,000 | $1.91 | $48K | Direct | Mar 13, 2007 (1d) |
| Mar 9, 2007 | AGEN | ↑ Buy | 50,000 | $1.83 | $91K | Direct | Mar 12, 2007 (3d) |
| Feb 9, 2007 | AGEN | ↑ Buy | 50,000 | $1.93 | $97K | Direct | Feb 13, 2007 (4d) |
| Nov 15, 2006 | CLRK | ↓ Sell | 190,000 | $17.95 | $3.4M | Direct | Nov 17, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Garo H Armen's insider trades
Garo H Armen is Exec. Chair & Principal Off at Protagenic Therapeutics, Inc.\new (PTIX). Since Nov 15, 2006, Garo has reported 25 open-market purchases worth $9.2M and 6 sales worth $5.3M on SEC Form 4. In the last 12 months: 7 buys ($31K).
Their filings also include grants and awards (176 filings), other transactions (80 filings), shares returned to the company (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.